Kalvista Pharmaceuticals Inc (KALV) earnings · rev $49.1M
These earnings events as JSON? API free 100/dayKalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
This KALV earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KALV revenue for 2025-12-31 was $49.1M. Net income was -$109.5M. Revenue was down 1.8% from 2024-04-30 to 2025-12-31. KALV currently screens at market cap $1.44B.
When the next KALV 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 1.8% from 2024-04-30 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KALV research stays on the stock page; the tape stays on the quote page.
KALV earnings FAQ
What are KALV's latest revenue and net income?
Latest cached Kalvista Pharmaceuticals Inc (KALV) revenue for Dec 31, 2025 was $49.1M. Net income was -$109.5M. Statements: https://lician.com/financials/kalv
What is KALV's latest diluted EPS?
Latest cached Kalvista Pharmaceuticals Inc (KALV) diluted EPS for Dec 31, 2025 was -$2.03.
What period does the latest KALV earnings print cover?
The latest cached Kalvista Pharmaceuticals Inc (KALV) earnings print covers Dec 31, 2025. The prior cached period on this page is Apr 30, 2024.
How did KALV revenue change from the prior cached period?
Cached Kalvista Pharmaceuticals Inc (KALV) revenue was down 1.8% from $50.0M (Apr 30, 2024) to $49.1M (Dec 31, 2025). Statements: https://lician.com/financials/kalv
Where are KALV earnings listed?
Cached earnings facts for Kalvista Pharmaceuticals Inc (KALV) are listed at https://lician.com/earnings/kalv. Statements: https://lician.com/financials/kalv
Not investment advice.